SCHEMBL16645429

SCHEMBL16645429

CC1=NN(c2ccccc2)C(=O)C1/N=N/c1cccc(C)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.81
▸ ALDH1A1 P00352 7/20 0.81
▸ NPC1 O15118 6/20 0.81
▸ RAB9A P51151 5/20 0.81
▸ SMN1; SMN2 Q16637 4/20 0.81
▸ LMNA P02545 3/20 0.81
▸ MAPK1 P28482 3/20 0.81
▸ TDP1 Q9NUW8 2/20 0.81
▸ MEN1 O00255 11/20 0.78
▸ KMT2A Q03164 11/20 0.78
▸ POLB P06746 3/20 0.68
▸ L3MBTL1 Q9Y468 2/20 0.68
▸ KDM4E B2RXH2 1/20 0.68
▸ ATM Q13315 1/20 0.65
▸ CYP1A2 P05177 2/20 0.63
▸ CYP2D6 P10635 1/20 0.63
▸ CYP2C9 P11712 1/20 0.63
▸ GAA P10253 1/20 0.63
▸ CASP3 P42574 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305975 0.90 MAPT (1.00) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL305974 0.90 MAPT (1.00) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL15765846 0.86 MAPT (0.73) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL3833053 0.86 MAPT (0.73) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL3833049 0.86 MAPT (0.73) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL3833055 0.86 MAPT (0.73) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL1086712 0.85 MAPT (0.72) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL2120385 0.85 MAPT (0.72) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL2120386 0.85 MAPT (0.72) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL1689493 0.84 MAPT (0.70) MAPTALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150101132-A1 CATIONIC DYE BEARING AN ANIONIC ORGANIC COUNTERION, DYE COMPOSITION COMPRISING THEM AND PROCESS FOR DYEING KERATIN USING THESE DYES L'OREAL (FR) 2015-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150101132-A1 CATIONIC DYE BEARING AN ANIONIC ORGANIC COUNTERION, DYE COMPOSITION COMPRISING THEM AND PROCESS FOR DYEING KERATIN USING THESE DYES KRT18, COL14A1, COL1A1 MAPT 574/4885ALDH1A1 1317/4885NPC1 4790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback